Cite
HARVARD Citation
Gonsalves, W. et al. (2018). Combination therapy incorporating Bcl‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14). European journal of haematology. pp. 215-217. [Online].